Cultural context in medical ethics: lessons from Japan by Powell, Tia
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Philosophy, Ethics, and Humanities 
in Medicine
Open Access Research
Cultural context in medical ethics: lessons from Japan
Tia Powell*
Address: New York State Task Force on Life & the Law, New York, NY, USA
Email: Tia Powell* - tpp03@health.state.ny.us
* Corresponding author    
Abstract
This paper examines two topics in Japanese medical ethics: non-disclosure of medical information
by Japanese physicians, and the history of human rights abuses by Japanese physicians during World
War II. These contrasting issues show how culture shapes our view of ethically appropriate
behavior in medicine. An understanding of cultural context reveals that certain practices, such as
withholding diagnostic information from patients, may represent ethical behavior in that context.
In contrast, nonconsensual human experimentation designed to harm the patient is inherently
unethical irrespective of cultural context. Attempts to define moral consensus in bioethics, and to
distinguish between acceptable and unacceptable variation across different cultural contexts,
remain central challenges in articulating international, culturally sensitive norms in medical ethics.
This paper examines two quite different topics in Japanese
medical ethics: non-disclosure of medical information by
Japanese physicians, and the history of human rights
abuses by Japanese physicians during World War II. An
analysis of these contrasting issues shows how culture
shapes our view of ethically appropriate behavior in med-
icine. A grasp of cultural context reveals that certain prac-
tices, such as withholding diagnostic information from
patients, may represent ethical behavior in that context. In
contrast, nonconsensual human experimentation
designed to harm the patient is inherently unethical irre-
spective of cultural context. The attempt to define moral
consensus in bioethics, and to distinguish between
acceptable and unacceptable variation across different
cultural contexts, remain central challenges in articulating
international, culturally sensitive norms in medical ethics.
Non-disclosure of medical information
The non-disclosure of medical information by Japanese
physicians is the most widely discussed topic in Japanese
medical ethics, with more than 3000 articles published on
this subject within a five year period [1]. Up until the
1980's, the unquestioned practice of Japanese doctors was
to withhold a wide range of information from patients,
particularly but not exclusively regarding cancer and poor
prognoses. Diagnoses concealed from Japanese patients
could extend to HIV seropositivity [2]. Psychiatric illness
is highly stigmatized in Japan; for patients with schizo-
phrenia, only 7% of psychiatrists in one study "always"
informed a patient of the diagnosis [3]. When refering
patients for psychiatric counseling, physicians might not
reveal the nature of the referral, using instead vague terms
such as "insomnia specialist " [4]. Reportedly, medicines
of various types could be dispensed to patients with the
labels removed [2].
Starting in the late 1980's and continuing today, Japanese
physicians' practices regarding disclosure have been
changing, with disclosure becoming more common,
though not as prevalent as in the US. For instance, in a
1992 study of Japanese physicians, only 13% reported
that they usually communicated cancer diagnoses to their
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patients [4]. More recent data show a marked and rapid
increase in disclosure by Japanese physicians; one study
documents an increase from 27% to 71% during the
period from 1993 to 1998 [5].
Many factors contribute to the shift in disclosure practices
in Japan. A widely reported medical malpractice case drew
national attention to the potential for increased risk to
patients because of nondisclosure. The case involved a
nurse who was evaluated for abdominal pain in 1983 [4].
Her doctor diagnosed bladder cancer, but told the patient
that she had gallstones and recommended surgery. The
patient did not follow up with treatment for six months,
by which time the cancer was no longer operable; the
patient died several months later. A malpractice case
ensued, unusual in Japan at that time [6]. The Japanese
Supreme Court concurred with the physicians' choice to
conceal the cancer diagnosis. The Court did urge physi-
cians to select false diagnoses of equivalent urgency to true
ones, so that patients will not unduly delay treatment [4].
Japanese society has devoted significant resources to the
debate on disclosure practices. Two important official
groups were convened and developed contrasting sets of
recommendations in 1989 and 1990. The Government
Task Force on Terminal Care was an appointed group
including both physicians and non-physicians. It recom-
mended that disclosure of cancer diagnoses be increased,
though not without assessing four patient-related factors:
psychological stability; decisional capacity; positive rela-
tionships between providers, family and patient; and
available supports for the patient [7]. In contrast, the
Bioethics Council of the Japan Medical Association, com-
posed only of physicians, recommended against disclo-
sure of cancer diagnoses, except in rare circumstances, i.e.
when the patient excelled in all four factors listed above.
Weakness in any single factor should preclude disclosure
[7]. These two reports suggest that not only was Japan
focused on the issue of disclosure, but that in the late 80's
there was no general consensus on the ethically correct
stance.
The Japanese government supports efforts to increase dis-
closure by way of a 1996 Ministry of Health regulation,
revised in 1997, that permits physicians to bill the Japa-
nese national health system specifically for documented
disclosure of the patient's diagnosis and treatment plan
[8]. In a nationalized system where physician fees are
tightly controlled and are far lower than in the U.S., addi-
tional billing options provide a strong inducement
toward disclosure.
The emotional tenor of discussions about disclosure in
Japan is reflected by surgeon and hospice advocate Fumio
Yamazaki's best-selling book, Dying in a Japanese Hospital
[9]. Yamazaki gained notoriety as a disclosure advocate,
arguing in his book that some patients, though by no
means all, should be informed of their terminal diag-
noses. Yamazaki painstakingly confronts the criticism that
disclosure can be harmful to patients; he goes so far as to
describe a case in which disclosure proved emotionally
disastrous for both patient and physician. This case
involved an elderly woman with extreme cancer-related
pain, who demanded repeatedly and forcefully to be told
her true diagnosis. Dr. Yamazaki did so, though without
using the word cancer, in the presence of her daughter-in-
law, who supported the patient with tearful embraces.
Subsequently, the doctor describes the following events:
[The patient] didn't say a word to me or to the nurses for
24 hours after that. No matter how many times we spoke
to her, she turned away and kept silent. Did she lose her
speech because she was so shocked with knowing the
truth? Or did she lose her speech because she was enraged
with knowing how people she had trusted had betrayed
her? [9]
When the patient's oldest son visited the hospital later
that day, he attacked the doctor for breaking a promise to
the family and telling his mother the truth. Dr. Yamazaki's
pain in this encounter, and his sense of having tried and
failed  to act as an ethical physician by disclosing the
patient's diagnosis is palpable.
The tone of the bioethics literature on nondisclosure in
Japan can be harshly judgmental. Various articles attribute
nondisclosure exclusively to the arrogance and paternal-
ism of Japanese physicians [1,6,7]. Those who strive to
increase disclosure portray themselves or are portrayed as
reformers [7]. Repeatedly, comparisons are made between
rates of disclosure in Japan and rates in the United States
or elsewhere at an earlier date, with the implication that
Japan lags behind the West by just this many years [2,7].
One account asserts that the Japanese practice of nondis-
closure lacks any basis in principled behavior, but merely
reflects culturally based conventions in which doctors
have greater social status than many patients [1]. Accord-
ing to this view of nondisclosure, paternalism, hierarchy,
and a lack of respect for patients provide a full explana-
tion.
However, differences in social status between doctors and
patients surely do not explain why Emperor Hirohito,
who had been revered as a living god, fell ill from cancer
in 1988, and did not have his diagnosis explicitly revealed
to him [10]. It is widely assumed that the Emperor did
eventually know his diagnosis, since he could observe the
nature of his treatments and the reactions of others. The
Emperor's physicians presumably relied upon ishin den-
shin, the Japanese term for non-verbal communication,Philosophy, Ethics, and Humanities in Medicine 2006, 1:4 http://www.peh-med.com/content/1/1/4
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which is viewed as appropriate and effective in many cir-
cumstances, particularly highly emotional ones [1,11].
Such indirect communication permits people to selec-
tively avoid painful and unnecessary information and dis-
cussion.
Those unfamiliar with Japanese culture may see only the
overt behavior, non-disclosure, and rush to the judgment
that Japanese patients are treated disrespectfully by their
physicians. However, knowledge of Japan's cultural con-
text reveals that the ethical propriety of disclosure prac-
tices is more nuanced than is captured in some of the
bioethics literature. For instance, when Japanese physi-
cians practice nondisclosure, they generally do not con-
ceal medical information from all concerned parties.
Families, rather than patients, are often informed about
diagnoses; decisions about whether or not to tell the
patient are left to family members, who often decide
against disclosure [2,4,7,12]. This process occurs irrespec-
tive of a patient's decision-making capacity. Michael Fet-
ters argues that this practice is not an abrogation of
autonomy, but a different form of autonomy, which he
labels "family autonomy" [13]. In this paradigm, now the
subject of societal debate and revision, disclosure to fam-
ilies is consistent with the assumptions and preferences of
patients, families and physicians. Japanese physicians
defer to family judgments about patients' coping skills
and support systems. Only rarely would a Japanese physi-
cian inform a patient against the wishes of the family.
Is the idea of "family autonomy" a contradiction in terms?
At first glance, an arrangement that precludes independ-
ent individual action seems inconsistent with autonomy.
However, for individuals who prize group identity and
welfare then a choice reached by consensus may be the
best expression of the individual's values. From this per-
spective, we might say that individuals can express auton-
omy by delegating authority to the family.
Surveys of Japanese views on disclosure reveal interesting
anomalies. In the 1990s, surveys reported that a large per-
centage of Japanese wanted to know their own diagnosis
but would not want a family member informed. Fetters
describes this as the "cancer disclosure paradox" [13]. He
argues that the desire of individuals to know their own
diagnosis suggests the increasing influence of individual-
ism and a desire for personal autonomy. At the same time,
notions of family responsibility support continued non-
disclosure for significant others. In this view, a Japanese
family cares for its members by shielding them from hurt-
ful information. To permit a loved one to be informed
without family assessment and approval is to fail in a cru-
cial moral duty within Japanese and many cultures
[14,15]. Though Japanese patients may wish disclosure
for themselves, they believe they should protect family
members from similar, potentially harmful direct disclo-
sure.
Both taking care of others and allowing others to take care,
including by making decisions, is accepted in a variety of
Japanese cultural contexts. For instance, the concept of
omakase describes the practice of placing oneself in the
care of a professional [11]. In a measure of respect and
trust, the client invites the professional to take responsi-
bility for decision-making. The professional accepts this
responsibility as a sign that the client depends on him,
and is deserving of the utmost concern. This form of inter-
action exists within traditional Japanese doctor-patient
relationships. It also exists in some Japanese restaurants,
in which patrons acknowledge their respect for the chef by
allowing him to choose for them. The chef's ability to
know clients' wishes better even than they themselves
know is a measure of the chef's skill. In fact, deference to
professional wisdom is not limited to Japan; Americans
when ill may also defer to the physician's judgment in a
manner that resembles the concept of omakase.
Medical anthropologist Susan Long argues that the shift
toward disclosure reflects the dissolution of a shared
moral consensus among Japanese physicians, families
and patients [16]. Current practices do not rise to the level
of a shared view of morally correct actions regarding dis-
closure, but reveal both variability and uncertainty. This
shift in disclosure practices represents an opportunity to
view a society and its members in the midst of a "moral
passage" away from one standard and toward a new one,
as yet imperfectly defined [16].
Long addresses the interplay of disclosure and autonomy
in offering a culturally sensitive analysis of Japanese prac-
tices [14]. She questions whether full disclosure is appro-
priate in the Japanese context, or merely an ill-suited
Western imposition, and finds that both systems have
much to learn from the other. Japanese physicians,
patients and families are paying increasing attention to
issues of patient autonomy. Americans, on the other
hand, may learn by re-evaluating the emphasis on the
doctor-patient dyad, which may undermine true auton-
omy by ignoring the importance of family participation in
the lives of Americans. Other authors suggest that pre-
dominant Western models, contrasting autonomy and
paternalism, fail to capture the range of options in the Jap-
anese doctor-patient relationship [17].
A number of authors have criticized Western and particu-
larly American bioethicists who place excessive value in
individual autonomy [18]. Indeed, some bioethicists
argue that U.S. practices inappropriately exclude families
from a role in decision-making, while excessively focusing
on individuals [19,20]. Such authors wish to borrow fromPhilosophy, Ethics, and Humanities in Medicine 2006, 1:4 http://www.peh-med.com/content/1/1/4
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other cultures a more inclusive approach to the role of
families [18].
Patients who wish for disclosure and shared decision-
making should have physicians who respect their wishes.
However, the practice of limited medical disclosure
remains common across most of the world today [15].
Nondisclosure cannot be attributed solely to physician
paternalism, for this practice may also reflect the prefer-
ences of patients and families. Some patients do not wish
for full disclosure; it is hard to argue that such patients
should behave as Western bioethicists would like them to
do, and that their physicians ought to impose autonomy-
based relationships upon them. Some authors suggest
that physicians need only inquire of patients about their
desires for information, and then proceed accordingly.
However, this practice stems from Western assumptions
about the benefit of frank discussion. In a model where it
is assumed that many important things will not and must
not be spoken, the invitation to frank discussion may
itself be an affront [21].
Japanese medical practices regarding disclosure are shift-
ing. More and more Japanese patients and physicians
expect and value candid discussion of medical informa-
tion [5]. Yet does the shift toward disclosure prove that it
is in some way more ethical than traditional practices? Per-
haps this shift merely documents that Japanese practices
are coalescing with Western ones, in a manner that does
not prove the intrinsic worth of one practice versus
another. Indeed, some bioethicists argue for an approach
to disclosure that attempts to balance respect for cultural
differences while encouraging shared decision-making
when patients choose it [18]. It remains to be seen
whether Japanese disclosure practices, once the current
phase of rapid change resolves, end up looking exactly like
American practices or like a new form.
In sum, full disclosure does not rise to the level of a uni-
versal norm. It was not the accepted standard in medicine
for the past thousands of years, and is not currently the
standard in most of the world. Nondisclosure is ethically
appropriate for some patients, partly because of culturally
shaped norms. Fuller disclosure is best for other patients
because of their individual culturally shaped preferences.
A practice may be culturally accepted, yet still ethically
unacceptable to others outside that culture. Practices like
female circumcision arguably fall into this category. How-
ever, nondisclosure of medical information, when con-
forming to cultural expectations and benefiting the
patient, need not be unethical. Other practices are not eth-
ically permissible, and cannot be made so by any degree
of cultural sensitivity. Egregious human rights abuses can
not be understood as ethical regardless of context, as we
shall see in the review of Japanese physician participation
in biological warfare experiments during World War II.
War crimes by Japanese physicians
Japanese physicians during World War II undertook bio-
logical warfare research that perpetrated significant abuse
of human subjects. These acts cannot be understood as
consistent with some different standard of medical ethics;
they profoundly violated the standards of medical ethics
even in that time and place. Indeed, the lead physician
and researcher in Japan's biological warfare efforts, Shiro
Ishii, addressed this dilemma in welcoming new staff
members, acknowledging that their work was "completely
opposite" to the physician's ethical obligation to cure dis-
ease [22]. A review of the abuse of human subjects in
World War II confirms that cultural context cannot justify
any and all behavior. Moreover, the abuse of research sub-
jects is not limited to one culture. Abuse by Nazi physi-
cians is widely known, and abuse in US government
sponsored research is also well documented [23]. Bioeth-
icists should study the cultural influences that promote
such abuses in order to prevent recurrence.
Crimes by Japanese physicians were not publicized as
were those by Nazi physicians, nor were Japanese physi-
cians tried in the Tokyo War Crimes trials. For the most
part, these acts have only gradually come to light in the
decades after the war, due to the work of a handful of Jap-
anese and other historians [24,25]. Significant additional
evidence regarding Japanese wartime activities comes
from the voluntary testimony of aging researchers and
other staff who have stepped forward in the last decade,
particularly in response to a traveling exhibit on biologi-
cal warfare research, which toured 61 locations in Japan
during 1993 and 1994 [26]. Japanese television documen-
taries have also publicized wartime biological warfare
activities [22].
Japanese physicians and scientists undertook a massive
program of biological warfare during WWII. A focus of
this activity was a facility known as Unit 731, whose head-
quarters near Harbin, China, ultimately grew to encom-
pass about 100 buildings, was under the direction of Shiro
Ishii [27]. Research at Unit 731 took as its starting point a
simple and correct observation: more soldiers die in war-
time from disease than in battle. Ishii supervised defen-
sive research that would prevent disease in Japanese
soldiers, as well as research that would increase disease in
civilian and military enemies of Japan. Substantial
amounts of research at Unit 731 included medical experi-
ments performed on prisoners, often causing terrible suf-
fering. Subjects died either as a result of experiments or
were put to death when no longer useful. Some prisoners
were combatants, while others were captured civilians,
including Chinese and Russian locals and Korean "com-Philosophy, Ethics, and Humanities in Medicine 2006, 1:4 http://www.peh-med.com/content/1/1/4
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fort women." Witnesses also report seeing infants used as
subjects in fatal experiments [26].
Research aimed at prevention of disease produced innova-
tions at Unit 731, but at the cost of human life. Under Dr.
Ishii's direction, researchers invented a portable water fil-
tration system that allowed Japanese soldiers to protect
their water supply while in contested areas or makeshift
camps. Researchers studying frostbite gained knowledge
about treatment by means of cruel experiments. They tied
up prisoners in subzero temperature until severely frost-
bitten, then subjected the prisoners to various experi-
ments, either to study potential treatments or to
understand the physiology of freezing; prisoners died
both due to frostbite and due to the experimental treat-
ments [27]. Principle researchers in this work had illustri-
ous post-war careers, with some serving on prestigious
committees; one Unit 731 researcher served after the war
on a prestigious committee on frostbite research, and ulti-
mately became president of a publicly funded medical
school [26,27].
Research was conducted on sexually transmitted disease,
always the scourge of armies. Unit 731 staff members
reported witnessing forced sex acts by infected prisoners,
including Korean comfort women. Former staff of Unit
731 have testified that vivisection was a common means
of studying disease processes [26].
Unit 731 conducted substantial research into biological
warfare, a violation of existing treaty obligations. Such
research focused on methods of disseminating disease
agents such as cholera, bubonic plague, and malaria.
Indeed, residents in the area of Harbin, China, reported
outbreaks of bubonic plague for decades after the war;
these outbreaks were the subject of a lawsuit of Chinese
citizens against the Japanese government [28]. Unit 731
researchers designed various bombs for biological war-
fare; these bombs were used in China and against Soviet
troops [23]. Bombs carrying infected fleas were dropped
in areas where prisoners were tied to stakes, and careful
measurements were taken in order to determine the effi-
cacy of different methods. Civilian water supplies in local
areas were also reportedly subject to intentional infection
as part of biological warfare research [26]. Large numbers
of research subjects as well as local residents are said to
have died as a result of intentional exposure to toxic
agents, either as a way to study the natural history of a dis-
ease, or its most effective route of transmission [22].
Japanese physicians do not appear to have planned a
wholesale program of genocide as did the Nazis. None-
theless, war crimes in the form of the horrific abuse of
human subjects did occur and were known at the end of
the war. Why then were these crimes, similar to those of
the Nazi physicians, not publicized by trials like those at
Nuremberg? A number of factors contributed to protect
the secrecy of these crimes and their perpetrators. As the
war neared its end, Unit 731 was dismantled with orders
to preserve secrecy; there were no survivors among those
incarcerated at Unit 731. Research records were destroyed,
remaining prisoners were executed, and bodies were
burned to destroy evidence.
However, not all evidence of Unit 731 was successfully
suppressed. A few photographs remain, including photo-
graphs of bodies stacked and awaiting incineration. Like-
wise, some documents, including hundreds of autopsy
reports of murdered research subjects, survived the
attempt to destroy evidence [22]. Furthermore, numerous
staff members were apprehended and interrogated; the
Soviets held trials of staff from Unit 731 [24]. Some Japa-
nese physicians and others served prison terms for as long
as 11 years in China and the Soviet Union [27,23].
Most of the senior staff of Unit 731, including Dr. Ishii,
returned to Japan as the war ended. These highly ranked
staff members came under the exclusive jurisdiction of US
military forces at the end of the war. America, already at
the start of the Cold War, was reluctant to share secrets of
biological warfare with its erstwhile allies, the Soviets and
the Chinese. American military authorities chose not to
include Dr. Ishii or any other participant in medical atroc-
ities in the public war crimes trials in Tokyo, apparently in
the hope of acquiring and maintaining the secrecy of val-
uable information from research into biological warfare
[27]. Such a policy was consistent with lenient treatment
arranged for various German scientists after the war [23].
However, current scholarship casts doubt on the value of
information obtained from Dr. Ishii, and suggests rather
that US military authorities bungled both the process of
debriefing him and the option of trying him for war
crimes [23]. Dr. Ishii negotiated clemency for himself and
a range of senior workers, and lived out the post-war years
at his home in Tokyo, ultimately dying of cancer.
Tanaka and other authors carefully weigh the issue of why
Japanese physicians were willing to grossly abuse human
subjects in the pursuit of research [27]. Drawing upon the
concept of "doubling" used by Robert Jay Lifton in analyz-
ing the motives of Nazi physicians [29], Tanaka argues
that Japanese physicians were able to ignore the suffering
of captive research subjects by creating a kind of separate
self who conducted research, different from the self in
other contexts. The researchers could follow different eth-
ical rules from those of other people, since they were
working to support the Emperor and Japan. All other eth-
ical norms, including the norms of medical ethics, were
subordinate to these goals. Research subjects were viewed
not as suffering humans, but as non-human experimentalPhilosophy, Ethics, and Humanities in Medicine 2006, 1:4 http://www.peh-med.com/content/1/1/4
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material. Infamously, researchers at Unit 731 referred to
their prisoners as "maruta," the Japanese word for log.
Neither medical training nor medical ethics prevented
these doctors from succumbing to the psychological and
military structures that constitute "atrocity-producing sit-
uations" [30].
Conclusion
This paper examines two contrasting issues in Japanese
medical ethics. The first section analyzes the workaday
issue of how physicians share information with patients,
and argues that a range of practices may suit ethical norms
in different cultural contexts. The second topic, the gross
abuse of human subjects during wartime, is one that fewer
physicians will directly confront. However, the collabora-
tion of physicians in the abuse of prisoners of war does
recur.
Non-disclosure of medical information to patients can
constitute an ethical practice when certain conditions
apply. First, the overt and credible intent of the physician
in withholding information must be to benefit the
patient. Withholding diagnostic information to protect a
third party, for instance to conceal medical error, does not
meet criteria for ethical behavior. Second, the patient
must also view this practice as beneficial. Ascertaining the
patient's view is inherently difficult when medical prac-
tices cannot be frankly discussed. However, either through
the patient's expressed views or the family's interpretation
of those views, patients in the past and to a lesser extent
today indicate that they view the withholding of certain
types of medical information as beneficial. Third, the
patient must at least tacitly agree to the practice of with-
holding information in the current instance. In a culture
where such practices are the norm, physicians may have
greater confidence in family statements about the
patient's beliefs. However, members of a culture may
accept a practice as applied to others but not to them-
selves. In the current climate of change, careful assessment
of beliefs with both patients and families provide an ethi-
cal foundation for selecting the best approach to disclo-
sure.
By contrast, the abuse of research subjects as documented
in Unit 731 can never be ethical. Research, unlike medical
treatment, poses an inherent ethical challenge, in that it is
never only in the patient's interest, but always brings with
it potentially competing claims, such as the good of other
patients in the future. Consent is important for ethical
treatment, yet even more critical in the ethical practice of
research, as noted in various codes of research ethics. In
the case of Unit 731, no pretense of consent was made; the
subjects were held as prisoners without rights, whether
they were civilians or combatants, adults or children. Nei-
ther was there any pretense of benefit to the subject; the
overt goal was to use the lives of these subjects in order to
gain benefit for others. No recorded attempt was made to
preserve the life or minimize the suffering of the victims.
It is possible, though far from certain, that a cultural
standard in Japan during WWII may have supported such
abuse of prisoners. Japanese citizens and soldiers made
enormous sacrifices to support the war, even to the point
of committing suicide. However, it is not enough for a
standard to exist in a culture for it to serve as the basis of
an ethical practice; it must at a minimum be accepted by
those to whom it is applied in the specific instance. Since
no prisoner of Unit 731 was there voluntarily, none can
be said to have accepted the role of subhuman research
material.
Contemporary emphasis on cultural sensitivity and cul-
tural competence enriches bioethics by broadening the
understanding of ethical practices internationally. A
greater awareness of practices around the world leads to
modesty in asserting the ethical universality of certain
practices, such as modes of communicating medical infor-
mation. Many aspects of medical practice are deeply
shaped by culture; the meaning of illness, the nature of
healing, and styles of communication between doctor,
patient, and family are all bound by culture and language.
Yet it is important to distinguish between cultural compe-
tency and cultural relativism. Understanding the context
of a time and place may permit us to discern ethical prin-
ciples behind behaviors that at first strike us as merely
wrong. However, other behaviors will remain ethically
unacceptable regardless of our grasp of the cultural con-
text. Indeed, the rational for some behaviors may elude
understanding, irrespective of efforts to place motives
within a context. Behavior during wartime, either by phy-
sicians or others, can fall to a level of barbarism that defies
acceptance or understanding. The tragedy is that the
capacity for egregious behavior under extraordinary cir-
cumstances exists in a wide range of cultures and peoples,
our own included.
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